View in EDS

Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Authors: O'Brien MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Forleo-Neto E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Sarkar N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Isa F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Hou P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Chan KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Musser BJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Bar KJ; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA., Barnabas RV; Department of Global Health, University of Washington, Seattle, WA, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Cohen MS; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA., Hurt CB; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA., Burwen DR; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Marovich MA; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Brown ER; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA., Heirman I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Turner KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Ramesh D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Mahmood A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Kim Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Purcell LA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Baum A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Kyratsous CA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Krainson J; Clinical Trials of Florida, LLC, Miami, FL, USA., Perez-Perez R; Medical Research of Westchester, Miami, FL, USA., Mohseni R; Catalina Research Institute, LLC, Montclair, CA, USA., Kowal B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., DiCioccio AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Braunstein N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Herman G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Weinreich DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Corporate Authors: COVID-19 Phase 3 Prevention Trial Team
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Sep 18. Date of Electronic Publication: 2021 Sep 18.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34159343
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22O'Brien+MP%22">O'Brien MP</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Forleo-Neto+E%22">Forleo-Neto E</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sarkar+N%22">Sarkar N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Isa+F%22">Isa F</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hou+P%22">Hou P</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chan+KC%22">Chan KC</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Musser+BJ%22">Musser BJ</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bar+KJ%22">Bar KJ</searchLink>; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Barnabas+RV%22">Barnabas RV</searchLink>; Department of Global Health, University of Washington, Seattle, WA, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Barouch+DH%22">Barouch DH</searchLink>; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+MS%22">Cohen MS</searchLink>; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hurt+CB%22">Hurt CB</searchLink>; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Burwen+DR%22">Burwen DR</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Marovich+MA%22">Marovich MA</searchLink>; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brown+ER%22">Brown ER</searchLink>; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Heirman+I%22">Heirman I</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JD%22">Davis JD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Turner+KC%22">Turner KC</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ramesh+D%22">Ramesh D</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mahmood+A%22">Mahmood A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hooper+AT%22">Hooper AT</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+JD%22">Hamilton JD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Purcell+LA%22">Purcell LA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Baum+A%22">Baum A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kyratsous+CA%22">Kyratsous CA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Krainson+J%22">Krainson J</searchLink>; Clinical Trials of Florida, LLC, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Perez-Perez+R%22">Perez-Perez R</searchLink>; Medical Research of Westchester, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Mohseni+R%22">Mohseni R</searchLink>; Catalina Research Institute, LLC, Montclair, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kowal+B%22">Kowal B</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22DiCioccio+AT%22">DiCioccio AT</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Stahl+N%22">Stahl N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lipsich+L%22">Lipsich L</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Braunstein+N%22">Braunstein N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Herman+G%22">Herman G</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yancopoulos+GD%22">Yancopoulos GD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Weinreich+DM%22">Weinreich DM</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22COVID-19+Phase+3+Prevention+Trial+Team%22">COVID-19 Phase 3 Prevention Trial Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101767986%22">MedRxiv : the preprint server for health sciences</searchLink> [medRxiv] 2021 Sep 18. <i>Date of Electronic Publication: </i>2021 Sep 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Preprint; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101767986 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>NLM ISO Abbreviation: </i>medRxiv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34159343
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1101/2021.06.14.21258569
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: O'Brien MP
      – PersonEntity:
          Name:
            NameFull: Forleo-Neto E
      – PersonEntity:
          Name:
            NameFull: Sarkar N
      – PersonEntity:
          Name:
            NameFull: Isa F
      – PersonEntity:
          Name:
            NameFull: Hou P
      – PersonEntity:
          Name:
            NameFull: Chan KC
      – PersonEntity:
          Name:
            NameFull: Musser BJ
      – PersonEntity:
          Name:
            NameFull: Bar KJ
      – PersonEntity:
          Name:
            NameFull: Barnabas RV
      – PersonEntity:
          Name:
            NameFull: Barouch DH
      – PersonEntity:
          Name:
            NameFull: Cohen MS
      – PersonEntity:
          Name:
            NameFull: Hurt CB
      – PersonEntity:
          Name:
            NameFull: Burwen DR
      – PersonEntity:
          Name:
            NameFull: Marovich MA
      – PersonEntity:
          Name:
            NameFull: Brown ER
      – PersonEntity:
          Name:
            NameFull: Heirman I
      – PersonEntity:
          Name:
            NameFull: Davis JD
      – PersonEntity:
          Name:
            NameFull: Turner KC
      – PersonEntity:
          Name:
            NameFull: Ramesh D
      – PersonEntity:
          Name:
            NameFull: Mahmood A
      – PersonEntity:
          Name:
            NameFull: Hooper AT
      – PersonEntity:
          Name:
            NameFull: Hamilton JD
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Purcell LA
      – PersonEntity:
          Name:
            NameFull: Baum A
      – PersonEntity:
          Name:
            NameFull: Kyratsous CA
      – PersonEntity:
          Name:
            NameFull: Krainson J
      – PersonEntity:
          Name:
            NameFull: Perez-Perez R
      – PersonEntity:
          Name:
            NameFull: Mohseni R
      – PersonEntity:
          Name:
            NameFull: Kowal B
      – PersonEntity:
          Name:
            NameFull: DiCioccio AT
      – PersonEntity:
          Name:
            NameFull: Stahl N
      – PersonEntity:
          Name:
            NameFull: Lipsich L
      – PersonEntity:
          Name:
            NameFull: Braunstein N
      – PersonEntity:
          Name:
            NameFull: Herman G
      – PersonEntity:
          Name:
            NameFull: Yancopoulos GD
      – PersonEntity:
          Name:
            NameFull: Weinreich DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 09
              Text: 2021 Sep 18
              Type: published
              Y: 2021
          Titles:
            – TitleFull: MedRxiv : the preprint server for health sciences
              Type: main
ResultId 1